Coca-Cola Europacific Partners PLC (CCEP) Stock Analysis
Latest ClaritX AI analysis ·
Coca-Cola Europacific Partners PLC (CCEP), along with its affiliated entities, focuses on the creation, distribution, and sale of a wide array of non-alcoholic, ready-to-consume beverages. Their diverse product portfolio includes sparkling drinks, still and enhanced water products, isotonic options, teas, coffees, juices, as well as a variety of energy drinks and mixers. These offerings are marketed under numerous prominent brands, notably flagship names such as Coca-Cola, Fanta, Sprite, and Monster Energy, among a host of others. In addition to its primary beverage business, CCEP also oversees bottling operations and other related activities. As of March 15, 2022, the company served an esti
| Metric | Value |
|---|---|
| Price | $111.87 |
| Market cap | $49.6B |
| Sector | Consumer Defensive |
| Industry | Beverages - Non-Alcoholic |
| ClaritX AI score | 72/100 |
| Price/Book | 5.38 |
| Dividend yield | 2.03% |
| Beta | 0.48 |
AI verdict
Coca-Cola Europacific Partners (CCEP) exemplifies the strengths of a premier consumer staple, offering exceptional business quality, robust capital returns, and a dominant global market presence. Fundamentally, the company boasts a stellar ROE of 24.78%, solid operating margins, and a highly secure dividend with a payout ratio of just 47.66%. Management's execution of a massive €1 billion share buyback program, heavily active throughout October 2026, acts as a powerful catalyst for EPS growth and provides a sturdy technical floor for the stock price. Coupled with strategic global expansions, such as the $39.7 million capacity upgrade in Western Australia, CCEP is operating from a position of profound corporate strength. Its exceptionally low beta of 0.482 makes it an ideal, low-volatility anchor for risk-averse portfolios. However, momentum awareness is absolutely critical in this assessment. The stock is currently trading at $111.87, less than 2% away from its 52-week high of $113.67. This euphoric near-term price action has driven the RSI to an extreme overbought level of 81.23. Furthermore, trading at a 22.4x TTM P/E, the stock has essentially hit the consensus analyst price target of $112, and strict DCF models suggest it is fundamentally overvalued. A beaten-down stock with these excellent fundamentals would be a screaming buy, but a stock sitting precisely at its 52-week high on extreme technical overextension warrants near-term caution. CCEP is a high-quality hold, bu
What this score has been worth
ClaritX scores CCEP 72 out of 100 (snapshot 2026-10-23).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 299 analyses that scored in the 70-79 band, the average forward return was +1.6% with a 56% win rate, -1.1pp against the S&P 500. That is a measured tendency across many names, not a forecast for CCEP — roughly 44% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.